Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors

American Journal of Roentgenology

Volumn 188, Issue 1, 2007, Pages 204-212

  Spampinato, M Vittoria ^a,b   Smith, J Keith ^a   Kwock, Lester ^a   Ewend, Matthew ^a   Grimme, John D ^a   Camacho, Daniel L A ^a   Castillo, Mauricio ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Brain; MR technique; MRI; Oncologic imaging; Perfusion weighted MRI

Indexed keywords

CHOLINE; CREATINE; GADOLINIUM PENTETATE MEGLUMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BLOOD VOLUME; BRAIN METABOLISM; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; METABOLITE; OLIGODENDROGLIOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE DRUG DOSE; TUMOR DIAGNOSIS;

ADULT; AGED; BLOOD VOLUME; BLOOD VOLUME DETERMINATION; BRAIN NEOPLASMS; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33845735110     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.1177     Document Type: Article

References (38)

1. Perry JR. Oligodendrogliomas: clinical and genetic correlations. Curr Opin Neurol 2001; 14:705-710
2. Cairncross JG, Macdonald DR, Ramsay DA. Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery 1992; 31:78-82
3. Reifenberger G, Kros J, Burger P, Louis D, Collims V. World Health Organization classification of tumours: pathology and genetics of tumours of the nervous system. Lyon, France: IARC Press, 2000:56-69
4. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 1992; 76:428-434
5. Bauman GS, Cairncross JG. Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligoastrocytomas. Semin Radiat Oncol 2001; 11:170-180
6. Kyritsis AP, Yung WK, Bruner J, Gleason MJ, Levin VA. The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 1993; 32:365-370
7. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 2004; 22:3133-3138
8. Fortin D, Macdonald DR, Stitt L, Cairncross JG. PCV for oligodendroglial tumors: in search of prognostic factors for response and survival. Can J Neurol Sci 2001; 28:215-223
9. Shaw EG, Scheithauer BW, O'Fallon JR, Davis DH. Mixed oligoastrocytomas: a survival and prognostic factor analysis. Neurosurgery 1994; 34:577-582
10. Daumas-Duport C, Tucker ML, Kolles H, et al. Oligodendrogliomas. Part II. A new grading system based on morphological and imaging criteria. J Neurooncol 1997; 34:61-78
11. White ML, Zhang Y, Kirby P, Ryken TC. Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? Am J Neuroradiol 2005; 26:784-790
12. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999; 211:791-798
13. Smith JK, Castillo M, Kwock L. MR spectroscopy of brain tumors. Magn Reson Imaging Clin N Am 2003; 11:415-429
14. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 2003; 24:1989-1998
15. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002; 222:715-721
16. Tzika AA, Vajapeyam S, Barnes PD. Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: preliminary observations. Am J Neuroradiol 1997; 18:203-218
17. Henry RG, Vigneron DB, Fischbein NJ, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. Am J Neuroradiol 2000; 21:357-366
18. Xu M, See SJ, Ng WH, et al. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 2005; 56:919-924
19. Rijpkema M, Schuuring J, van der Meulen Y, et al. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging. NMR Biomed 2003; 16:12-18
20. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [published correction appears in Am J Neuroradiol 2004; 25:B1]. Am J Neuroradiol 2004; 25:214-221
21. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II. Experimental comparison and preliminary results. Magn Reson Med 1996; 36:726-736
22. Ostergaard L, Weisskoff RM, Chester DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and statistical analysis. Magn Reson Med 1996; 36:715-725
23. Sorensen AG, Reimer P. Cerebral MR Perfusion Imaging: Principles and Current Applications. New York: NY, Thieme Medical Publishers, 2001
24. Weisskoff R, Boxerman J, Sorensen A, Kulke S, Campbell T, Rosen B. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: Proceedings of the Second Meeting of the Society of Magnetic Resonance. Berkeley, CA: International Society for Magnetic Resonance in Medicine, 1994
25. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial masslesions: interobserver and intraobserverreproducibility study. Radiology 2002; 224:797-803
26. Smith JK, Kwock L, Castillo M. Effects of contrast material on single-volume proton MR spectroscopy. Am J Neuroradiol 2000;21:1084-1089
27. Varlet P, Guillamo JS, Nataf F, Koziak M, Beuvon F, Daumas-Duport C. Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival. Neuropathol Appl Neurobiol 2000; 26:379-389
28. Reiche W, Grunwald I, Hermann K, Deinzer M, Reith W. Oligodendrogliomas. Acta Radiol 2002; 43:474-482
29. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologice findings. Radiology 1994; 191:41-51
30. Cha S, Tihan T, Crawford F, et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. Am J Neuroradiol 2005; 26:266-273
31. Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Ucoz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. Am J Neuroradiol 2003; 24:225-233
32. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. Am J Neuroradiol 2001; 22:604-612
33. Gupta RK, Cloughesy TF, Sinha U, et al. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000; 50:215-226
34. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002; 44:656-666
35. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. Am J Neuroradiol 2000; 21:1645-1649
36. Castillo M, Kwock L. Proton MR spectroscopy of common brain tumors. Neuroimaging Clin N Am 1998; 4:733-752
37. Soffietti R. Chemotherapy of anaplastic oligodendroglial tumours. Expert Opin Pharmacother 2004; 5:295-306
38. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998; 90:1473-1479